Home
Mirum Pharmaceuticals

Mirum Pharmaceuticals Market Share Analysis for May 2026

Mirum Pharmaceuticals, Inc.'s MIRM lead product, Livmarli (maralixibat), , is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) worldwide.

Health > Biotechnology and Pharmaceuticals

Domainmirumpharma.com

Year Founded2018

Employees201 - 500

Annual Revenue$200M - $500M

Mirum Pharmaceuticals

Mirum Pharmaceuticals (including company regionals)

mirumpharma.com

See more website traffic and engagement information

Mirum Pharmaceuticals Revenue up to May 2026 is 200M - 500M

revenue generated by Mirum Pharmaceuticals top domains

Mirum Pharmaceuticals top domains revenue over 3 years

Revenue for Mirum Pharmaceuticals top domains

mirumpharma.com200M - 500M

See more with Sales Intelligence

Total visits to Mirum Pharmaceuticals's top domains

Understand Mirum Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

mirumpharma.com16.1K

See more with Sales Intelligence

Avg. visit duration in Mirum Pharmaceuticals's top domains

Analyze Mirum Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

mirumpharma.com00:00:04

See more with Sales Intelligence

Avg. pageviews on Mirum Pharmaceuticals's top domains

See how Mirum Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

mirumpharma.com1.66

See more with Sales Intelligence

Mirum Pharmaceuticals top competitors by domain

Top similar sites in May 2026, ranked by their affinity

adverum.comCompany NameAdverumEmployees51 - 200HQUnited States, California, Redwood CityAnnual revenue$2M - $5MTotal visits3.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Mirum Pharmaceuticals

These are the website technologies, by industry, used by Mirum Pharmaceuticals top domains

Payment & Currencies (10)

Cart Functionality

Widget (7)

Twemoji

eCommerce (5)

OpenCart

Conversion & Analytics (3)

Google Analytics

More Technologies

13

See all

News & Signals from Mirum Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMirumpharma signed new client U.S. Food and Drug Administration on May 1st '26.Mirum announced last month that the FDA has accepted its drug package for zilurgisertib, with a target action date of September 26.

NewsMirumpharma attended event EASL Congress on May 30th '26.Mirum Pharmaceuticals (MIRM) reports positive Phase 2b data for volixibat in PSC at EASL Congress.